- Population
The population density of Monsey, NY was 9,712 in 2018. The population density of Central Falls, RI was 16,177 in 2018.
Population Density
Population Density is computed by dividing the total population by Land Area Per Square Mile.
Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API -
Geographic and Population Datasets Involving Monsey, NY or Central Falls, RI
- API
NYCHA Development Data Book
data.cityofnewyork.us | Last Updated 2024-05-13T15:53:04.000ZContains the main body of the "Development Data Book". The Development Data Book lists all of the Authority's Developments alphabetically and includes information on the development identification numbers, program and construction type, number of apartments and rental rooms, population, number of buildings and stories, street boundaries, and political districts.
- API
Long-term Industry Projections
data.ny.gov | Last Updated 2023-06-30T17:36:30.000ZLong-term Industry Projections for a 10 year time horizon are provided for the state and 10 labor market regions to provide individuals and organizations with an industry outlook.
- API
Short-term Industry Projections
data.ny.gov | Last Updated 2024-03-06T19:36:11.000ZShort-term Industry Projections for a 2 year time horizon are provided for the state and 10 labor market regions to provide individuals and organizations with an industry outlook.
- API
Incidence Of Brain And Central Nervous System Cancer Age 15 Under Per 1,000,000 All States
opendata.utah.gov | Last Updated 2019-04-19T01:42:51.000ZIncidence Of Brain And Central Nervous System Cancer Age 15 Under Per 1,000,000 All States
- API
All Payer Inpatient Quality Indicators (IQI) Volume Measures by Hospital (SPARCS): Beginning 2009
health.data.ny.gov | Last Updated 2020-11-16T17:30:25.000ZThe datasets contain hospital discharges counts (numerators, denominators, volume counts), observed, expected and risk-adjusted rates with corresponding 95% confidence intervals for IQIs generated using methodology developed by Agency for Healthcare Research and Quality (AHRQ). The IQIs are a set of measures that provide a perspective on hospital quality of care using hospital administrative data. These indicators reflect quality of care inside hospitals and include inpatient mortality for certain procedures and medical conditions; utilization of procedures for which there are questions of overuse, underuse, and misuse; and volume of procedures for which there is some evidence that a higher volume of procedures is associated with lower mortality. All the IQI measures were calculated using Statewide Planning and Research Cooperative System (SPARCS) inpatient data beginning 2009. US Census data files provided by AHRQ were used to derive denominators for county level (area level) IQI measures. The mortality, volume and utilization measures IQIs are presented by hospital as rates or counts. Area-level utilization measures are presented by county as rates.
- API
All Payer Patient Safety Indicators (PSI) Volume Measures by Hospital: Beginning 2009
health.data.ny.gov | Last Updated 2024-05-24T19:46:18.000ZThe datasets contain hospital discharges counts (numerators, denominators, volume counts), observed, expected and risk-adjusted rates with corresponding 95% confidence intervals for Patient Safety Indicators generated using methodology developed by Agency for Healthcare Research and Quality (AHRQ). The PSIs are a set of indicators providing information on potential in hospital complications and adverse events following surgeries, procedures, and childbirth. The PSIs were developed by AHRQ after a comprehensive literature review, analysis of ICD-9-CM codes, review by a clinician panel, implementation of risk adjustment, and empirical analyses. All PSI measures were calculated using Statewide Planning and Research Cooperative System (SPARCS) inpatient data beginning 2009. US Census data files provided by AHRQ were used to derive denominators for county level (area level) PSI measures. The mortality, volume and utilization measures PSIs are presented by hospital as rates or counts. Area-level measures are presented by county as rates.
- API
Hospital Inpatient Discharges (SPARCS De-Identified): 2012
health.data.ny.gov | Last Updated 2019-09-13T16:29:09.000ZThe Statewide Planning and Research Cooperative System (SPARCS) Inpatient De-Identified dataset contains discharge level detail on patient characteristics, diagnoses, treatments, services, and charges. This data contains basic record level detail regarding the discharge; however, the data does not contain protected health information (PHI) under Health Insurance Portability and Accountability Act (HIPAA). The health information is not individually identifiable; all data elements considered identifiable have been redacted. For example, the direct identifiers regarding a date have the day and month portion of the date removed.
- API
NYSERDA Low- to Moderate-Income New York State Census Population Analysis Dataset: Average for 2013-2015
data.ny.gov | Last Updated 2019-11-15T22:30:02.000ZHow does your organization use this dataset? What other NYSERDA or energy-related datasets would you like to see on Open NY? Let us know by emailing OpenNY@nyserda.ny.gov. The Low- to Moderate-Income (LMI) New York State (NYS) Census Population Analysis dataset is resultant from the LMI market database designed by APPRISE as part of the NYSERDA LMI Market Characterization Study (https://www.nyserda.ny.gov/lmi-tool). All data are derived from the U.S. Census Bureau’s American Community Survey (ACS) 1-year Public Use Microdata Sample (PUMS) files for 2013, 2014, and 2015. Each row in the LMI dataset is an individual record for a household that responded to the survey and each column is a variable of interest for analyzing the low- to moderate-income population. The LMI dataset includes: county/county group, households with elderly, households with children, economic development region, income groups, percent of poverty level, low- to moderate-income groups, household type, non-elderly disabled indicator, race/ethnicity, linguistic isolation, housing unit type, owner-renter status, main heating fuel type, home energy payment method, housing vintage, LMI study region, LMI population segment, mortgage indicator, time in home, head of household education level, head of household age, and household weight. The LMI NYS Census Population Analysis dataset is intended for users who want to explore the underlying data that supports the LMI Analysis Tool. The majority of those interested in LMI statistics and generating custom charts should use the interactive LMI Analysis Tool at https://www.nyserda.ny.gov/lmi-tool. This underlying LMI dataset is intended for users with experience working with survey data files and producing weighted survey estimates using statistical software packages (such as SAS, SPSS, or Stata).
- API
Rates of COVID-19 Cases or Deaths by Age Group and Updated (Bivalent) Booster Status
data.cdc.gov | Last Updated 2023-06-01T16:51:17.000ZData for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Updated (Bivalent) Booster Status. Click 'More' for important dataset description and footnotes Webpage: https://covid.cdc.gov/covid-data-tracker/#rates-by-vaccine-status Dataset and data visualization details: These data were posted and archived on May 30, 2023 and reflect cases among persons with a positive specimen collection date through April 22, 2023, and deaths among persons with a positive specimen collection date through April 1, 2023. These data will no longer be updated after May 2023. Vaccination status: A person vaccinated with at least a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. A person vaccinated with a primary series and a monovalent booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably receiving a primary series of an FDA-authorized or approved vaccine and at least one additional dose of any monovalent FDA-authorized or approved COVID-19 vaccine on or after August 13, 2021. (Note: this definition does not distinguish between vaccine recipients who are immunocompromised and are receiving an additional dose versus those who are not immunocompromised and receiving a booster dose.) A person vaccinated with a primary series and an updated (bivalent) booster dose had SARS-CoV-2 RNA or antigen detected in a respiratory specimen collected ≥14 days after verifiably receiving a primary series of an FDA-authorized or approved vaccine and an additional dose of any bivalent FDA-authorized or approved vaccine COVID-19 vaccine on or after September 1, 2022. (Note: Doses with bivalent doses reported as first or second doses are classified as vaccinated with a bivalent booster dose.) People with primary series or a monovalent booster dose were combined in the “vaccinated without an updated booster” category. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Per the interim guidance of the Council of State and Territorial Epidemiologists (CSTE), this should include persons whose death certificate lists COVID-19 disease or SARS-CoV-2 as the underlying cause of death or as a significant condition contributing to death. Rates of COVID-19 deaths by vaccination status are primarily reported based on when the patient was tested for COVID-19. In select jurisdictions, deaths are included that are not laboratory confirmed and are reported based on alternative dates (i.e., onset date for most; or date of death or report date, where onset date is unavailable). Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 24 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Colorado, District of Columbia, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (NY), North Carolina, Rhode Island, Tennessee, Texas, Utah, and West Virginia; 23 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 48% of the total U.S. population and all ten of the Health and Human Services Regions. This list will be
- API
All Payer Inpatient Quality Indicators (IQI) Composite Measures by Hospital (SPARCS): Beginning 2009
health.data.ny.gov | Last Updated 2024-05-24T19:46:32.000ZThe datasets contain hospital discharges counts (numerators, denominators, volume counts), observed, expected and risk-adjusted rates with corresponding 95% confidence intervals for IQIs generated using methodology developed by Agency for Healthcare Research and Quality (AHRQ). The IQIs are a set of measures that provide a perspective on hospital quality of care using hospital administrative data. These indicators reflect quality of care inside hospitals and include inpatient mortality for certain procedures and medical conditions; utilization of procedures for which there are questions of overuse, underuse, and misuse; and volume of procedures for which there is some evidence that a higher volume of procedures is associated with lower mortality. All the IQI measures were calculated using Statewide Planning and Research Cooperative System (SPARCS) inpatient data beginning 2009. US Census data files provided by AHRQ were used to derive denominators for county level (area level) IQI measures. The mortality, volume and utilization measures IQIs are presented by hospital as rates or counts. Area-level utilization measures are presented by county as rates.